Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chalazion × Triamcinolone Acetonide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uveal Melanoma 2 Lymphoma, T-Cell, Cutaneous 2 Lichen Planus, Oral 2 Stomach Neoplasms 1 Retinal Diseases 1 Radiodermatitis 1 Pain 1 Neuroma, Acoustic 1 Mycosis Fungoides 1 Melanoma 1 Macular Degeneration 1 Lymphomatoid Papulosis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Leiomyoma 1 Fibroma 1 Esophageal Stenosis Acquired 1 Dupuytren Contracture 1 Disease 1 Dermatitis, Contact 1 Choroid Diseases 1 Chalazion 1 Castration Resistant Prostate Cancer 1 Breast Neoplasms 1 Adenomyosis 1 Acute Gout 1

Interventions

Conservative Treatment 3 Probiotics 2 Curettage 2 Triamcinolone Acetonide 1 Triamcinolone 1 Tetracycline 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡